doi: 10.2337/DB20-0636 Summary Keywords autoimmunity, coxsackievirus B (CVB), enterovirus, HLA, immune tolerance, stem cell-derived islets, type I interferon (IFN), cells Citation Veronese-Paniagua DA and Millman JR (2025) The perfect storm: unraveling the interplay of genetic predisposition and viral triggers in type 1 diabetes pathogenesis
Sahebkar A, Simental-Mendia LE, Mikhailidis DP, Pirro M, Banach M, Sirtori CR, et al
One author disclosed ties to the pharmaceutical industry
The weight loss data confirm that continued treatment beyond 48 weeks produces additional weight reduction: The 28.7% at 68 weeks exceeds the 24.2% at 48 weeks from Phase 2, representing approximately 4.5 additional percentage points of weight loss over the additional 20 weeks of treatment
Reduced Gastrointestinal Side Effects Because liposomal glutathione is more easily absorbed, it minimizes the gastrointestinal discomfort sometimes associated with high doses of glutathione or other supplements